Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Rangering i aksjer
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Aksjekurs
$20.91
Markedsverdi
$7.57B
Endring (1 dag)
-8.26%
Endring (1 år)
41.25%
Land
CN
Handel Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Kategori
Healthcare
Antall utestående aksjer for Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Antall utestående aksjer per June 2026: 356.25M
Ifølge Asymchem Laboratories (Tianjin) Co., Ltd. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 356.25M. Ved slutten av December 2024 hadde selskapet 352.77M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Asymchem Laboratories (Tianjin) Co., Ltd. (002821) fra 2011 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 356.25M | -0.60% |
| 2025 | 358.41M | 1.60% |
| 2024 | 352.77M | -2.67% |
| 2023 | 362.43M | -0.98% |
| 2022 | 366.03M | 7.77% |
| 2021 | 339.64M | 4.15% |
| 2020 | 326.11M | 1.78% |
| 2019 | 320.42M | 0.46% |
| 2018 | 318.94M | 0.80% |
| 2017 | 316.43M | 23.41% |
| 2016 | 256.40M | 1.98% |
| 2015 | 251.42M | -0.31% |
| 2014 | 252.21M | 0.04% |
| 2013 | 252.10M | 0.13% |
| 2012 | 251.78M | 0.41% |
| 2011 | 250.74M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 253.90M | -28.73% |
US
|
|
| 396.00M | 11.16% |
US
|
|
| 478.91M | 34.43% |
AU
|
|
| 0.00 | -100.00% |
BE
|
|
| 62.19M | -82.54% |
NL
|
